{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:31:43Z","timestamp":1790775103983,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The effect of metabolic syndrome on chronic liver diseases other than non-alcoholic fatty liver disease has not been fully elucidated. Our goal was to evaluate if metabolic syndrome increased the risk of liver-related complications, specifically hepatocellular carcinoma (HCC) and decompensation, in cirrhotic chronic hepatitis C (CHC) patients. We conducted a retrospective cohort study of 3503 consecutive cirrhotic CHC patients seen at Stanford University from 1997\u20132015. HCC developed in 238 patients (8-year incidence 21%) and hepatic decompensation in 448 patients (8-year incidence 61%). The incidence of HCC and decompensation increased with Hispanic ethnicity, diabetes, and number of metabolic risk factors. Multivariate Cox regression analysis demonstrated that, independent of HCV therapy and cure and other background risks, Hispanic ethnicity with \u22652 metabolic risk factors significantly increased the risk of HCC and hepatic decompensation. There was no interaction between Hispanic ethnicity and metabolic risk factors. All in all, metabolic risk factors significantly increase the risk of liver-related complications in cirrhotic CHC patients, especially HCC among Hispanics. As the prevalence of metabolic syndrome increases globally, targeted health interventions are needed to help curb the effects of metabolic syndrome in CHC patients.<\/jats:p>","DOI":"10.1038\/s41598-018-25533-2","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T14:22:12Z","timestamp":1525184532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors"],"prefix":"10.1038","volume":"8","author":[{"given":"Alina","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hsuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansen","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindie H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"25533_CR1","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","volume":"387","author":"(NCD-RisC), N. R. F. C","year":"2016","unstructured":"(NCD-RisC), N. R. F. C. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants. Lancet 387, 1377\u20131396, https:\/\/doi.org\/10.1016\/S0140-6736(16)30054-X (2016).","journal-title":"Lancet"},{"key":"25533_CR2","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1001\/jama.2015.4260","volume":"313","author":"M Aguilar","year":"2015","unstructured":"Aguilar, M., Bhuket, T., Torres, S., Liu, B. & Wong, R. J. Prevalence of the metabolic syndrome in the United States, 2003\u20132012. JAMA 313, 1973\u20131974, https:\/\/doi.org\/10.1001\/jama.2015.4260 (2015).","journal-title":"JAMA"},{"key":"25533_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2337\/dc10-0879","volume":"34","author":"A Mozumdar","year":"2011","unstructured":"Mozumdar, A. & Liguori, G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999\u20132006. Diabetes Care 34, 216\u2013219, https:\/\/doi.org\/10.2337\/dc10-0879 (2011).","journal-title":"Diabetes Care"},{"key":"25533_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384, https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatology"},{"key":"25533_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.12.029","author":"A Kasmari","year":"2017","unstructured":"Kasmari, A. et al. Independent of Cirrhosis, Hepatocellular Carcinoma risk is increased with Diabetes and Metabolic Syndrome: A retrospective cohort study. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2016.12.029 (2017).","journal-title":"Am J Med"},{"key":"25533_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"POH Collaborators","year":"2017","unstructured":"Collaborators, P. O. H. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2, 161\u2013176, https:\/\/doi.org\/10.1016\/S2468-1253(16)30181-9 (2017).","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"25533_CR7","first-page":"293","volume":"12","author":"RJ Wong","year":"2016","unstructured":"Wong, R. J. & Gish, R. G. Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection. Gastroenterol Hepatol (N Y) 12, 293\u2013299 (2016).","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"25533_CR8","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.ejca.2012.02.063","volume":"48","author":"Y Chen","year":"2012","unstructured":"Chen, Y., Wang, X., Wang, J., Yan, Z. & Luo, J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer 48, 2137\u20132145, https:\/\/doi.org\/10.1016\/j.ejca.2012.02.063 (2012).","journal-title":"Eur J Cancer"},{"key":"25533_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cgh.2008.02.012","volume":"6","author":"T Ohki","year":"2008","unstructured":"Ohki, T. et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 6, 459\u2013464, https:\/\/doi.org\/10.1016\/j.cgh.2008.02.012 (2008).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"25533_CR10","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/hep.26087","volume":"57","author":"Y Arase","year":"2013","unstructured":"Arase, Y. et al. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology 57, 964\u2013973, https:\/\/doi.org\/10.1002\/hep.26087 (2013).","journal-title":"Hepatology"},{"key":"25533_CR11","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/hep.22251","volume":"47","author":"BJ Veldt","year":"2008","unstructured":"Veldt, B. J. et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47, 1856\u20131862, https:\/\/doi.org\/10.1002\/hep.22251 (2008).","journal-title":"Hepatology"},{"key":"25533_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1053\/jhep.2001.0103306le01","volume":"33","author":"SH Mehta","year":"2001","unstructured":"Mehta, S. H. et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Hepatology 33, 1554, https:\/\/doi.org\/10.1053\/jhep.2001.0103306le01 (2001).","journal-title":"Hepatology"},{"key":"25533_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/gut.2010.236158","volume":"61","author":"AJ Thompson","year":"2012","unstructured":"Thompson, A. J. et al. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2\/3. Gut 61, 128\u2013134, https:\/\/doi.org\/10.1136\/gut.2010.236158 (2012).","journal-title":"Gut"},{"key":"25533_CR14","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","volume":"33","author":"LE Adinolfi","year":"2001","unstructured":"Adinolfi, L. E. et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33, 1358\u20131364, https:\/\/doi.org\/10.1053\/jhep.2001.24432 (2001).","journal-title":"Hepatology"},{"key":"25533_CR15","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1128\/JVI.00125-07","volume":"81","author":"G Waris","year":"2007","unstructured":"Waris, G., Felmlee, D. J., Negro, F. & Siddiqui, A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 81, 8122\u20138130, https:\/\/doi.org\/10.1128\/JVI.00125-07 (2007).","journal-title":"J Virol"},{"key":"25533_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s10620-015-3983-3","volume":"61","author":"HK Dyal","year":"2016","unstructured":"Dyal, H. K. et al. Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review. Dig Dis Sci 61, 636\u2013645, https:\/\/doi.org\/10.1007\/s10620-015-3983-3 (2016).","journal-title":"Dig Dis Sci"},{"key":"25533_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/ajg.2016.330","volume":"111","author":"JD Yang","year":"2016","unstructured":"Yang, J. D. et al. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. Am J Gastroenterol 111, 1573\u20131580, https:\/\/doi.org\/10.1038\/ajg.2016.330 (2016).","journal-title":"Am J Gastroenterol"},{"key":"25533_CR18","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/hep.510290632","volume":"29","author":"G Svegliati-Baroni","year":"1999","unstructured":"Svegliati-Baroni, G. et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 29, 1743\u20131751, https:\/\/doi.org\/10.1002\/hep.510290632 (1999).","journal-title":"Hepatology"},{"key":"25533_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.diabres.2006.07.008","volume":"75","author":"M Shaheen","year":"2007","unstructured":"Shaheen, M. et al. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract 75, 320\u2013326, https:\/\/doi.org\/10.1016\/j.diabres.2006.07.008 (2007).","journal-title":"Diabetes Res Clin Pract"},{"key":"25533_CR20","doi-asserted-by":"publisher","unstructured":"Banks, D. E., Bogler, Y., Bhuket, T., Liu, B. & Wong, R. J. Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S. Diabetes Metab Syndr, https:\/\/doi.org\/10.1016\/j.dsx.2016.12.025 (2016).","DOI":"10.1016\/j.dsx.2016.12.025"},{"key":"25533_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/gut.2010.213553","volume":"59","author":"M Stepanova","year":"2010","unstructured":"Stepanova, M., Rafiq, N. & Younossi, Z. M. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 59, 1410\u20131415, https:\/\/doi.org\/10.1136\/gut.2010.213553 (2010).","journal-title":"Gut"},{"key":"25533_CR22","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/ajg.2014.214","volume":"109","author":"HB El-Serag","year":"2014","unstructured":"El-Serag, H. B., Kramer, J., Duan, Z. & Kanwal, F. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans. Am J Gastroenterol 109, 1427\u20131435, https:\/\/doi.org\/10.1038\/ajg.2014.214 (2014).","journal-title":"Am J Gastroenterol"},{"key":"25533_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-115","volume":"12","author":"SR Bozeman","year":"2012","unstructured":"Bozeman, S. R. et al. Predicting waist circumference from body mass index. BMC Med Res Methodol 12, 115, https:\/\/doi.org\/10.1186\/1471-2288-12-115 (2012).","journal-title":"BMC Med Res Methodol"},{"key":"25533_CR24","unstructured":"Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications\u2014Part 1: Diagnosis and Classification of Diabetes Mellitus. (World Health Organization, Geneva, 1999)."},{"key":"25533_CR25","unstructured":"The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. (World Health Organization, Sydney, Australia, 2000)."},{"key":"25533_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang, P. L. A comprehensive definition for metabolic syndrome. Dis Model Mech 2, 231\u2013237, https:\/\/doi.org\/10.1242\/dmm.001180 (2009).","journal-title":"Dis Model Mech"},{"key":"25533_CR27","doi-asserted-by":"publisher","unstructured":"Bruix, J., Sherman, M. & Diseases, A. A. f. t. S. o. L. Management of hepatocellular carcinoma: an update. Hepatology 53, 1020\u20131022, https:\/\/doi.org\/10.1002\/hep.24199 (2011).","DOI":"10.1002\/hep.24199"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25533-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:04:21Z","timestamp":1671599061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25533-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25533"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25533-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Nguyen MH: grant\/research support: B.K. Kee Foundation, Pfizer, Asian Health Foundation, Gilead, BMS, Janssen, NCI; Advisory board\/consultant: BMS, Janssen, Gilead, Intercept, Novartis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7164"}}